Evidence map›Paper›PMID 34549306›Full record

ArticleOncology reports2021

Identification of the tumor‑suppressive role of circular RNA‑FOXO3 in colorectal cancer via regulation of miR‑543/LATS1 axis.

Yun-Yao Deng, Yu-Juan Min, Kun Zhou, Qing-Song Yang, Mei Peng, Zhao-Rui Cui, Xiang-Lian Zhu, Hao Liu, Min Wang, Xie Zhang and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. The regulatory roles of circular RNAsFrontiers in neurology · 2022
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yun-Yao DengDepartment of General Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong 510630, P.R. China.
Yu-Juan MinDepartment of General Surgery, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China.
Kun ZhouDepartment of General Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong 510630, P.R. China.
Qing-Song YangDepartment of General Surgery, Suzhou Sunset Care Institute, Suzhou, Jiangsu 215008, P.R. China.
Mei PengDepartment of General Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong 510630, P.R. China.
Zhao-Rui CuiDepartment of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510630, P.R. China.
Xiang-Lian ZhuDepartment of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510630, P.R. China.
Hao LiuDepartment of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510630, P.R. China.
Min WangDepartment of General Surgery, Women and Children's Hospital of Hunan, Changsha, Hunan 410008, P.R. China.
Xie ZhangDepartment of General Surgery, Xiangtan Medicine and Health Vocational College, Xiangtan, Hunan 411104, P.R. China.
Li-Xin LiuDepartment of General Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong 510630, P.R. China.
Third Affiliated Hospital of Southern Medical University · CNFirst Affiliated Hospital of Jinan University · CNNorth Sichuan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is a common malignancy with significant prevalence and mortality rates. Circular RNA FOXO3 (circ‑FOXO3; hsa_circ_0006404) has been reported to be involved in cancer regulation; however, its role in CRC is yet to be fully elucidated. Therefore, the aim of the present study was to investigate the effect of circ‑FOXO3 on CRC progression and identify its underlying mechanism. In the present study, the expression of circ‑FOXO3 was investigated in CRC tissues and cells via reverse transcription‑quantitative PCR. A Cell Counting Kit‑8 and colony formation assays were used to assess cell proliferation. The cell migratory and invasive abilities were detected using the Transwell migration and invasion assays. The luciferase assay and RNA pull‑down assay were conducted to verify the relationship of circ‑FOXO3, microRNA (miR)‑543 and Large tumor suppressor kinase 1 (LATS1). The results demonstrated that circ‑FOXO3 expression was downregulated in CRC tissues and cells, and was associated with poor overall survival of patients with CRC. Moreover, circ‑FOXO3 was associated with tumor size, distant metastasis, differentiation, lymph node metastasis and TMN stages of patients with CRC. circ‑FOXO3 overexpression suppressed CRC cell proliferation, migration and invasion. Luciferase assay and RNA pull‑down assay results indicated that circ‑FOXO3 functioned as a sponge for miR‑543. In addition, circ‑FOXO3 increased the expression of LATS1 via sponging miR‑543, thus inhibiting CRC cell aggressive features. Collectively, the present results suggested that circ‑FOXO3 inhibited CRC metastasis and progression via elevated LATS1 expression by sponging miR‑543. Therefore, circ‑FOXO3 may be a promising target for CRC therapy.

Indexed as

AdultAgedCell Line, TumorCell MovementCell ProliferationColorectal NeoplasmsDown-RegulationFemaleForkhead Box Protein O3HumansMaleMicroRNAsMiddle AgedProtein Serine-Threonine KinasesForkhead Box Protein O3FOXO3 protein, humanLATS1 protein, humanMicroRNAsMIRN543 microRNA, humanProtein Serine-Threonine Kinasescircular RNA FOXO3colorectal cancerinvasionlarge tumor suppressor kinase 1microRNA‑543migration

Identifiers

PMID34549306
PMCPMC8485021
OpenAlexW3201104803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.